speb/financial-data huggingface dataset:
PSA income_statement (annual, 2024-12-31) — Operating Revenue: 4695616000.00
PSA balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 175408393.00
PSA balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -71965000.00
PSA income_statement (annual, 2024-12-31) — Other Gand A: 77969000.00
PSA income_statement (annual, 2024-12-31) — Other Income Expense: 130526000.00
PSA balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 116344000.00
PSA cash_flow (annual, 2024-12-31) — Other Non Cash Items: 11410000.00
PSA balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 272212000.00
PSA income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 18075000.00
PSA income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 4623000.00
PSA balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 588248000.00
PSA balance_sheet (annual, 2024-12-31) — Preferred Shares Number: 174000000.00
PSA balance_sheet (annual, 2024-12-31) — Preferred Stock: 4350000000.00
PSA income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 194703000.00
PSA balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 4350000000.00
PSA cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
PSA income_statement (annual, 2024-12-31) — Pretax Income: 2089079000.00
PSA cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
PSA cash_flow (quarterly, 2024-12-31) — Purchase Of Business: 0.00
PSA cash_flow (annual, 2024-12-31) — Purchase Of Investment Properties: -594327000.00
PSA balance_sheet (annual, 2024-12-31) — Receivables: 9976000.00
PSA balance_sheet (quarterly, 2024-12-31) — Receivables: 9976000.00
PSA income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 1258001000.00
PSA income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1129766000.00
PSA cash_flow (annual, 2024-12-31) — Repayment Of Debt: -808505000.00
PSA cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -200000000.00
PSA cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: 0.00
PSA income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 15506000.00
PSA balance_sheet (annual, 2024-12-31) — Retained Earnings: -699083000.00
PSA income_statement (annual, 2024-12-31) — Salaries And Wages: 28708000.00
PSA income_statement (quarterly, 2024-12-31) — Salaries And Wages: 8781000.00
PSA cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
PSA cash_flow (annual, 2024-12-31) — Sale Of Investment Properties: 8388000.00
PSA income_statement (annual, 2024-12-31) — Selling General And Administration: 106677000.00
PSA balance_sheet (annual, 2024-12-31) — Share Issued: 175408393.00
PSA income_statement (annual, 2024-12-31) — Special Income Charges: -15506000.00
PSA cash_flow (annual, 2024-12-31) — Stock Based Compensation: 44747000.00
PSA balance_sheet (annual, 2024-12-31) — Stockholders Equity: 9712606000.00
PSA balance_sheet (annual, 2024-12-31) — Tangible Book Value: 5080419000.00
PSA income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 185260.00
PSA income_statement (annual, 2024-12-31) — Tax Provision: 4669000.00
PSA income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
PSA balance_sheet (annual, 2024-12-31) — Total Assets: 19754934000.00
PSA balance_sheet (annual, 2024-12-31) — Total Capitalization: 19065640000.00
PSA balance_sheet (annual, 2024-12-31) — Total Debt: 9353034000.00
PSA balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 9813652000.00
PSA income_statement (annual, 2024-12-31) — Total Expenses: 2494444000.00
PSA balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 9941282000.00
PSA balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 19297542000.00
PSA balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 9353034000.00
PSA income_statement (annual, 2024-12-31) — Total Unusual Items: 92630000.00
PSA income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 92630000.00
PSA balance_sheet (annual, 2024-12-31) — Working Capital: -130856000.00
PSA income_statement (quarterly, 2025-03-31) — +Operating Expense: 307899000.00
PSA income_statement (quarterly, 2025-03-31) — +Total Revenue: 1183184000.00
PSA balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 6124382000.00
PSA cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 3827000.00
PSA income_statement (quarterly, 2025-03-31) — Basic Average Shares: 877095000.00
PSA income_statement (quarterly, 2025-03-31) — Basic EPS: 0.41
PSA cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 447416000.00
PSA cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -58009000.00
PSA cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -58009000.00
PSA balance_sheet (quarterly, 2025-03-31) — Capital Stock: 4367543000.00
PSA balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 287177000.00
PSA balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 287177000.00
PSA cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -575844000.00
PSA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -578785000.00
PSA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -286517000.00
PSA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 705063000.00
PSA cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -79386000.00
PSA cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 8702000.00
PSA cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -79386000.00
PSA cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -70684000.00
PSA cash_flow (quarterly, 2025-03-31) — Changes In Cash: -160239000.00
PSA balance_sheet (quarterly, 2025-03-31) — Common Stock: 17543000.00
PSA balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 5216256000.00
PSA cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 3184000.00
PSA balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 240669000.00
PSA income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 331847000.00
PSA balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 520536000.00
PSA balance_sheet (quarterly, 2025-03-31) — Current Assets: 287177000.00
PSA balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 520536000.00
PSA cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 282715000.00
PSA income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 282715000.00
PSA cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 282715000.00
PSA income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 282715000.00
PSA income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 879710000.00
PSA income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.41
PSA income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 358230000.00
PSA cash_flow (quarterly, 2025-03-31) — Dividend Received Cfo: 432000.00
PSA income_statement (quarterly, 2025-03-31) — EBIT: 484226000.00
PSA income_statement (quarterly, 2025-03-31) — EBITDA: 766941000.00
PSA income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 3627000.00
PSA cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: -3627000.00
PSA cash_flow (quarterly, 2025-03-31) — End Cash Position: 287177000.00
PSA cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -578785000.00
PSA cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 647054000.00
PSA cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -45000.00
PSA income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -69523000.00
PSA balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -58244000.00
PSA income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 25184000.00
PSA balance_sheet (quarterly, 2025-03-31) — Goodwill: 165843000.00
PSA balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 263203000.00
PSA balance_sheet (quarterly, 2025-03-31) — Gross PPE: 240669000.00
PSA income_statement (quarterly, 2025-03-31) — Gross Profit: 851337000.00
PSA cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 230000.00
PSA income_statement (quarterly, 2025-03-31) — Interest Expense: 72009000.00
PSA income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 72009000.00
PSA income_statement (quarterly, 2025-03-31) — Interest Income: 8191000.00
PSA income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 8191000.00
PSA cash_flow (quarterly, 2025-03-31) — Interest Paid Cff: 0.00
PSA cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 82509000.00
PSA balance_sheet (quarterly, 2025-03-31) — Invested Capital: 14640814000.00
PSA cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -286517000.00
PSA balance_sheet (quarterly, 2025-03-31) — Investment Properties: 18158607000.00
PSA balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 374115000.00
PSA cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 3184000.00
PSA cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
PSA balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 9424558000.00
PSA balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 9424558000.00
PSA cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
PSA cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -33000.00
PSA balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 374115000.00
PSA balance_sheet (quarterly, 2025-03-31) — Minority Interest: 104096000.00
PSA income_statement (quarterly, 2025-03-31) — Minority Interests: -3000000.00
PSA cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 3184000.00
PSA balance_sheet (quarterly, 2025-03-31) — Net Debt: 9137381000.00
PSA cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 68664000.00
PSA income_statement (quarterly, 2025-03-31) — Net Income: 407791000.00
PSA income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 358230000.00
PSA income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 410791000.00
PSA income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 407791000.00
PSA income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 407791000.00
PSA cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 410791000.00
PSA income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 410791000.00
PSA income_statement (quarterly, 2025-03-31) — Net Interest Income: -63818000.00
PSA cash_flow (quarterly, 2025-03-31) — Net Investment Properties Purchase And Sale: -204872000.00
PSA cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -33000.00
PSA cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -33000.00
PSA income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -63818000.00
PSA cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -6092000.00
PSA cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -23636000.00
PSA balance_sheet (quarterly, 2025-03-31) — Net PPE: 240669000.00
PSA balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 9303053000.00
PSA income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 843887000.00
PSA income_statement (quarterly, 2025-03-31) — Normalized Income: 484470817.39
PSA cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 705063000.00
PSA cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 64992000.00
PSA income_statement (quarterly, 2025-03-31) — Operating Income: 543438000.00
PSA income_statement (quarterly, 2025-03-31) — Operating Revenue: 1183184000.00
PSA balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 175430172.00
PSA balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -58244000.00
PSA income_statement (quarterly, 2025-03-31) — Other Gand A: 25184000.00
PSA income_statement (quarterly, 2025-03-31) — Other Income Expense: -67403000.00
PSA balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 97360000.00
PSA cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 2707000.00
PSA balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 291675000.00
PSA income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 5916000.00
PSA income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 883000.00
PSA balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 520536000.00
PSA balance_sheet (quarterly, 2025-03-31) — Preferred Shares Number: 161350000.00
PSA balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 4350000000.00
PSA income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 48678000.00
PSA balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 4350000000.00
PSA income_statement (quarterly, 2025-03-31) — Pretax Income: 412217000.00
PSA cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
PSA cash_flow (quarterly, 2025-03-31) — Purchase Of Investment Properties: -207471000.00
PSA income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 331847000.00
PSA income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 282715000.00
PSA cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -33000.00
PSA income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 7423000.00
PSA balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -867425000.00
PSA income_statement (quarterly, 2025-03-31) — Salaries And Wages: 5963000.00
PSA cash_flow (quarterly, 2025-03-31) — Sale Of Investment Properties: 2599000.00
PSA income_statement (quarterly, 2025-03-31) — Selling General And Administration: 25184000.00
PSA balance_sheet (quarterly, 2025-03-31) — Share Issued: 175430172.00
PSA income_statement (quarterly, 2025-03-31) — Special Income Charges: -7423000.00
PSA cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 10283000.00
PSA balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 9566256000.00
PSA balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 4953053000.00
PSA income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -266182.61
PSA income_statement (quarterly, 2025-03-31) — Tax Provision: 1426000.00
PSA income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
PSA balance_sheet (quarterly, 2025-03-31) — Total Assets: 19615446000.00
PSA balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 18990814000.00
PSA balance_sheet (quarterly, 2025-03-31) — Total Debt: 9424558000.00
PSA balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 9670352000.00
PSA income_statement (quarterly, 2025-03-31) — Total Expenses: 639746000.00
PSA balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 9945094000.00
PSA balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 19328269000.00
PSA balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 9424558000.00
PSA income_statement (quarterly, 2025-03-31) — Total Unusual Items: -76946000.00
PSA income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -76946000.00
PSA balance_sheet (quarterly, 2025-03-31) — Working Capital: -233359000.00
PSA income_statement (quarterly, 2025-06-30) — +Operating Expense: 307930000.00
PSA income_statement (quarterly, 2025-06-30) — +Total Revenue: 1201094000.00
PSA balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 6131517000.00
PSA cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
PSA income_statement (quarterly, 2025-06-30) — Basic Average Shares: 877210000.00
PSA income_statement (quarterly, 2025-06-30) — Basic EPS: 0.35
PSA cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 287177000.00
PSA cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -55338000.00
PSA cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -55338000.00
PSA balance_sheet (quarterly, 2025-06-30) — Capital Stock: 4367545000.00
PSA balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1104603000.00
PSA balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1104603000.00
PSA cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -575847000.00
PSA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 282998000.00
PSA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -338280000.00
PSA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 872708000.00
PSA cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 95918000.00
PSA cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -31468000.00
PSA cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 95918000.00
PSA cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 64450000.00
PSA cash_flow (quarterly, 2025-06-30) — Changes In Cash: 817426000.00
PSA balance_sheet (quarterly, 2025-06-30) — Common Stock: 17545000.00
PSA balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 5022459000.00
PSA cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 4595000.00
PSA balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 257295000.00
PSA income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 318005000.00
PSA balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 624825000.00
PSA balance_sheet (quarterly, 2025-06-30) — Current Assets: 1104603000.00
PSA balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 624825000.00
PSA cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 283216000.00
PSA income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 283216000.00
PSA cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 283216000.00
PSA income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 283216000.00
PSA income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 879605000.00
PSA income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.35
PSA income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 308968000.00
PSA cash_flow (quarterly, 2025-06-30) — Dividend Received Cfo: 304000.00
PSA income_statement (quarterly, 2025-06-30) — EBIT: 436260000.00
PSA income_statement (quarterly, 2025-06-30) — EBITDA: 719476000.00
PSA income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: -2230000.00
PSA cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 2230000.00
PSA cash_flow (quarterly, 2025-06-30) — End Cash Position: 1104603000.00
PSA cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 282998000.00
PSA cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 817370000.00
PSA cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -163000.00
PSA income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -146822000.00
PSA balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -41461000.00
PSA income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 24714000.00
PSA balance_sheet (quarterly, 2025-06-30) — Goodwill: 165843000.00
PSA balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 253467000.00
PSA balance_sheet (quarterly, 2025-06-30) — Gross PPE: 257295000.00
PSA income_statement (quarterly, 2025-06-30) — Gross Profit: 883089000.00
PSA cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 5680000.00
PSA income_statement (quarterly, 2025-06-30) — Interest Expense: 71609000.00
PSA income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 71609000.00
PSA income_statement (quarterly, 2025-06-30) — Interest Income: 8122000.00
PSA income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 8122000.00
PSA cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 57176000.00
PSA balance_sheet (quarterly, 2025-06-30) — Invested Capital: 15462738000.00
PSA cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -338280000.00
PSA balance_sheet (quarterly, 2025-06-30) — Investment Properties: 18173526000.00
PSA balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 387946000.00
PSA cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 4595000.00
PSA cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 866532000.00
PSA balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 10440279000.00
PSA balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 10440279000.00
PSA cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 866532000.00
PSA cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -32000.00
PSA balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 387946000.00
PSA balance_sheet (quarterly, 2025-06-30) — Minority Interest: 103890000.00
PSA income_statement (quarterly, 2025-06-30) — Minority Interests: -2992000.00
PSA cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 4595000.00
PSA balance_sheet (quarterly, 2025-06-30) — Net Debt: 9335676000.00
PSA cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 147052000.00
PSA income_statement (quarterly, 2025-06-30) — Net Income: 358419000.00
PSA income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 308968000.00
PSA income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 361411000.00
PSA income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 358419000.00
PSA income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 358419000.00
PSA cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 361411000.00
PSA income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 361411000.00
PSA income_statement (quarterly, 2025-06-30) — Net Interest Income: -63487000.00
PSA cash_flow (quarterly, 2025-06-30) — Net Investment Properties Purchase And Sale: -238702000.00
PSA cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 866500000.00
PSA cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 866500000.00
PSA income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -63487000.00
PSA cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -12250000.00
PSA cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -44240000.00
PSA balance_sheet (quarterly, 2025-06-30) — Net PPE: 257295000.00
PSA balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 9118992000.00
PSA income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 869849000.00
PSA income_statement (quarterly, 2025-06-30) — Normalized Income: 507455904.61
PSA cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 872708000.00
PSA cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 149119000.00
PSA income_statement (quarterly, 2025-06-30) — Operating Income: 575159000.00
PSA income_statement (quarterly, 2025-06-30) — Operating Revenue: 1201094000.00
PSA balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 175452716.00
PSA balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -41461000.00
PSA income_statement (quarterly, 2025-06-30) — Other Gand A: 17655000.00
PSA income_statement (quarterly, 2025-06-30) — Other Income Expense: -147021000.00
PSA balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 87624000.00
PSA cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 3588000.00
PSA balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 364616000.00
PSA income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 5582000.00
PSA income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 778000.00
PSA balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 624825000.00
PSA balance_sheet (quarterly, 2025-06-30) — Preferred Shares Number: 174000000.00
PSA balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 4350000000.00
PSA income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 48673000.00
PSA balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 4350000000.00
PSA income_statement (quarterly, 2025-06-30) — Pretax Income: 364651000.00
PSA cash_flow (quarterly, 2025-06-30) — Purchase Of Investment Properties: -238952000.00
PSA income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 318005000.00
PSA income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 283216000.00
PSA cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -32000.00
PSA income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 3551000.00
PSA balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1085142000.00
PSA income_statement (quarterly, 2025-06-30) — Salaries And Wages: 7059000.00
PSA cash_flow (quarterly, 2025-06-30) — Sale Of Investment Properties: 250000.00
PSA income_statement (quarterly, 2025-06-30) — Selling General And Administration: 24714000.00
PSA balance_sheet (quarterly, 2025-06-30) — Share Issued: 175452716.00
PSA income_statement (quarterly, 2025-06-30) — Special Income Charges: -3551000.00
PSA cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 10620000.00
PSA balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 9372459000.00
PSA balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 4768992000.00
PSA income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -1336095.39
PSA income_statement (quarterly, 2025-06-30) — Tax Provision: 3240000.00
PSA income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.01
PSA balance_sheet (quarterly, 2025-06-30) — Total Assets: 20541453000.00
PSA balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 19812738000.00
PSA balance_sheet (quarterly, 2025-06-30) — Total Debt: 10440279000.00
PSA balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 9476349000.00
PSA income_statement (quarterly, 2025-06-30) — Total Expenses: 625935000.00
PSA balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 11065104000.00
PSA balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 19436850000.00
PSA balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 10440279000.00
PSA income_statement (quarterly, 2025-06-30) — Total Unusual Items: -150373000.00
PSA income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -150373000.00
PSA balance_sheet (quarterly, 2025-06-30) — Working Capital: 479778000.00
PSA income_statement (quarterly, 2025-09-30) — +Operating Expense: 317771000.00
PSA income_statement (quarterly, 2025-09-30) — +Total Revenue: 1224043000.00
PSA balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 6143166000.00
PSA cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 119000.00
PSA income_statement (quarterly, 2025-09-30) — Basic Average Shares: 877280000.00
PSA income_statement (quarterly, 2025-09-30) — Basic EPS: 0.53
PSA cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1104603000.00
PSA cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -75944000.00
PSA cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -75944000.00
PSA balance_sheet (quarterly, 2025-09-30) — Capital Stock: 4367546000.00
PSA balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 296460000.00
PSA balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 296460000.00
PSA cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -575855000.00
PSA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -987251000.00
PSA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -695983000.00
PSA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 875091000.00
PSA cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 50883000.00
PSA cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 10414000.00
PSA cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 50883000.00
PSA cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 61297000.00
PSA cash_flow (quarterly, 2025-09-30) — Changes In Cash: -808143000.00
PSA balance_sheet (quarterly, 2025-09-30) — Common Stock: 17546000.00
PSA balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 4962123000.00
PSA cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 1698000.00
PSA cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
PSA balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 267816000.00
PSA income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 330850000.00
PSA balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 664389000.00
PSA balance_sheet (quarterly, 2025-09-30) — Current Assets: 296460000.00
PSA balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 664389000.00
PSA cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 290364000.00
PSA income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 290364000.00
PSA cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 290364000.00
PSA income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 290364000.00
PSA income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 879420000.00
PSA income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.52
PSA income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 461408000.00
PSA cash_flow (quarterly, 2025-09-30) — Dividend Received Cfo: 1087000.00
PSA cash_flow (quarterly, 2025-09-30) — Dividends Received Cfi: 0.00
PSA income_statement (quarterly, 2025-09-30) — EBIT: 597296000.00
PSA income_statement (quarterly, 2025-09-30) — EBITDA: 887660000.00
PSA income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 3674000.00
PSA cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: -3674000.00
PSA cash_flow (quarterly, 2025-09-30) — End Cash Position: 296460000.00
PSA cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -987251000.00
PSA cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 799147000.00
PSA cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -502000.00
PSA income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 7549000.00
PSA balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -48365000.00
PSA income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 27407000.00
PSA balance_sheet (quarterly, 2025-09-30) — Goodwill: 165843000.00
PSA balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 269568000.00
PSA balance_sheet (quarterly, 2025-09-30) — Gross PPE: 267816000.00
PSA income_statement (quarterly, 2025-09-30) — Gross Profit: 893193000.00
PSA cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: -52000.00
PSA income_statement (quarterly, 2025-09-30) — Interest Expense: 79692000.00
PSA income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 79692000.00
PSA income_statement (quarterly, 2025-09-30) — Interest Income: 10331000.00
PSA income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 10331000.00
PSA cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 80834000.00
PSA balance_sheet (quarterly, 2025-09-30) — Invested Capital: 15004945000.00
PSA cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -695983000.00
PSA balance_sheet (quarterly, 2025-09-30) — Investment Properties: 18511954000.00
PSA balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 383557000.00
PSA cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 1698000.00
PSA cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
PSA balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 10042822000.00
PSA balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 10042822000.00
PSA cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
PSA cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -400034000.00
PSA balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 383557000.00
PSA balance_sheet (quarterly, 2025-09-30) — Minority Interest: 94984000.00
PSA income_statement (quarterly, 2025-09-30) — Minority Interests: -3710000.00
PSA cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 1698000.00
PSA balance_sheet (quarterly, 2025-09-30) — Net Debt: 9746362000.00
PSA cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -1141000.00
PSA income_statement (quarterly, 2025-09-30) — Net Income: 511063000.00
PSA income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 461408000.00
PSA income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 514773000.00
PSA income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 511063000.00
PSA income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 511063000.00
PSA cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 514773000.00
PSA income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 514773000.00
PSA income_statement (quarterly, 2025-09-30) — Net Interest Income: -69361000.00
PSA cash_flow (quarterly, 2025-09-30) — Net Investment Properties Purchase And Sale: -605076000.00
PSA cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -400034000.00
PSA cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -400034000.00
PSA income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -69361000.00
PSA cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -13060000.00
PSA cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -14963000.00
PSA balance_sheet (quarterly, 2025-09-30) — Net PPE: 267816000.00
PSA balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 9042555000.00
PSA income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 884324000.00
PSA income_statement (quarterly, 2025-09-30) — Normalized Income: 507745246.03
PSA cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 875091000.00
PSA cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -5317000.00
PSA income_statement (quarterly, 2025-09-30) — Operating Income: 575422000.00
PSA income_statement (quarterly, 2025-09-30) — Operating Revenue: 1224043000.00
PSA balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 175462847.00
PSA balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -48365000.00
PSA income_statement (quarterly, 2025-09-30) — Other Gand A: 21432000.00
PSA income_statement (quarterly, 2025-09-30) — Other Income Expense: 11543000.00
PSA balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 103725000.00
PSA cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 3310000.00
PSA balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 384963000.00
PSA income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 4533000.00
PSA income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 977000.00
PSA balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 664389000.00
PSA balance_sheet (quarterly, 2025-09-30) — Preferred Shares Number: 174000000.00
PSA balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 4350000000.00
PSA income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 48678000.00
PSA balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 4350000000.00
PSA income_statement (quarterly, 2025-09-30) — Pretax Income: 517604000.00
PSA cash_flow (quarterly, 2025-09-30) — Purchase Of Investment Properties: -606130000.00
PSA income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 330850000.00
PSA income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 290364000.00
PSA cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -400034000.00
PSA cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
PSA income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 4213000.00
PSA balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1150224000.00
PSA income_statement (quarterly, 2025-09-30) — Salaries And Wages: 5975000.00
PSA cash_flow (quarterly, 2025-09-30) — Sale Of Investment Properties: 1054000.00
PSA income_statement (quarterly, 2025-09-30) — Selling General And Administration: 27407000.00
PSA balance_sheet (quarterly, 2025-09-30) — Share Issued: 175462847.00
PSA income_statement (quarterly, 2025-09-30) — Special Income Charges: -4213000.00
PSA cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 9458000.00
PSA balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 9312123000.00
PSA balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 4692555000.00
PSA income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 18246.03
PSA income_statement (quarterly, 2025-09-30) — Tax Provision: 2831000.00
PSA income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.01
PSA balance_sheet (quarterly, 2025-09-30) — Total Assets: 20114318000.00
PSA balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 19354945000.00
PSA balance_sheet (quarterly, 2025-09-30) — Total Debt: 10042822000.00
PSA balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 9407107000.00
PSA income_statement (quarterly, 2025-09-30) — Total Expenses: 648621000.00
PSA balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 10707211000.00
PSA balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 19817858000.00
PSA balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 10042822000.00
PSA income_statement (quarterly, 2025-09-30) — Total Unusual Items: 3336000.00
PSA income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 3336000.00
PSA balance_sheet (quarterly, 2025-09-30) — Working Capital: -367929000.00
PSA income_statement (annual, 2025-12-31) — +Operating Expense: 1253647000.00
PSA income_statement (quarterly, 2025-12-31) — +Operating Expense: 320836000.00
PSA income_statement (annual, 2025-12-31) — +Total Revenue: 4824113000.00
PSA income_statement (quarterly, 2025-12-31) — +Total Revenue: 1215792000.00
PSA balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 6147650000.00
PSA balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 6147650000.00
PSA cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 4348000.00
PSA cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 402000.00
PSA income_statement (annual, 2025-12-31) — Basic Average Shares: 877235000.00
PSA income_statement (quarterly, 2025-12-31) — Basic Average Shares: 877340000.00
PSA income_statement (annual, 2025-12-31) — Basic EPS: 1.81
PSA income_statement (quarterly, 2025-12-31) — Basic EPS: 0.52
PSA cash_flow (annual, 2025-12-31) — Beginning Cash Position: 447416000.00
PSA cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 296460000.00
PSA cash_flow (annual, 2025-12-31) — Capital Expenditure: -289378000.00
PSA cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -100087000.00
PSA cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -289378000.00
PSA cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -100087000.00
PSA balance_sheet (annual, 2025-12-31) — Capital Stock: 4367550000.00
PSA balance_sheet (quarterly, 2025-12-31) — Capital Stock: 4367550000.00
PSA balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 318095000.00
PSA balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 318095000.00
PSA balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 318095000.00
PSA balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 318095000.00
PSA cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -2303381000.00
PSA cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -575835000.00
PSA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -1630681000.00
PSA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -347643000.00
PSA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1685089000.00
PSA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -364309000.00
PSA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 3186449000.00
PSA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 733587000.00
PSA cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 26440000.00
PSA cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -40975000.00
PSA cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -24639000.00
PSA cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -12287000.00
PSA cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 26440000.00
PSA cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -40975000.00
PSA cash_flow (annual, 2025-12-31) — Change In Working Capital: 1801000.00
PSA cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -53262000.00
PSA cash_flow (annual, 2025-12-31) — Changes In Cash: -129321000.00
PSA cash_flow (quarterly, 2025-12-31) — Changes In Cash: 21635000.00
PSA balance_sheet (annual, 2025-12-31) — Common Stock: 17550000.00
PSA balance_sheet (quarterly, 2025-12-31) — Common Stock: 17550000.00
PSA balance_sheet (annual, 2025-12-31) — Common Stock Equity: 4898128000.00
PSA balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 4898128000.00
PSA cash_flow (annual, 2025-12-31) — Common Stock Issuance: 9412000.00
PSA cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: -65000.00
PSA cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
PSA cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
PSA balance_sheet (annual, 2025-12-31) — Construction In Progress: 194355000.00
PSA balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 194355000.00
PSA income_statement (annual, 2025-12-31) — Cost Of Revenue: 1309975000.00
PSA income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 329273000.00
PSA balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 612889000.00
PSA balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 612889000.00
PSA balance_sheet (annual, 2025-12-31) — Current Assets: 460203000.00
PSA balance_sheet (quarterly, 2025-12-31) — Current Assets: 460203000.00
PSA balance_sheet (annual, 2025-12-31) — Current Liabilities: 612889000.00
PSA balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 612889000.00
PSA cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1151840000.00
PSA cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 295545000.00
PSA income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 1151840000.00
PSA income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 295545000.00
PSA cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1151840000.00
PSA cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 295545000.00
PSA income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 1151840000.00
PSA income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 295545000.00
PSA income_statement (annual, 2025-12-31) — Diluted Average Shares: 879510000.00
PSA income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 879295000.00
PSA income_statement (annual, 2025-12-31) — Diluted EPS: 1.80
PSA income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.52
PSA income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 1585585000.00
PSA income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 456979000.00
PSA cash_flow (annual, 2025-12-31) — Dividend Received Cfo: 1823000.00
PSA cash_flow (quarterly, 2025-12-31) — Dividend Received Cfo: 0.00
PSA cash_flow (annual, 2025-12-31) — Dividends Received Cfi: 0.00
PSA cash_flow (quarterly, 2025-12-31) — Dividends Received Cfi: 0.00
PSA income_statement (annual, 2025-12-31) — EBIT: 2094299000.00
PSA income_statement (quarterly, 2025-12-31) — EBIT: 576517000.00
PSA income_statement (annual, 2025-12-31) — EBITDA: 3246139000.00
PSA income_statement (quarterly, 2025-12-31) — EBITDA: 872062000.00
PSA income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 9604000.00
PSA income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 4533000.00
PSA cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: -9604000.00
PSA cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -4533000.00
PSA cash_flow (annual, 2025-12-31) — End Cash Position: 318095000.00
PSA cash_flow (quarterly, 2025-12-31) — End Cash Position: 318095000.00
PSA cash_flow (annual, 2025-12-31) — Financing Cash Flow: -1630681000.00
PSA cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -347643000.00
PSA cash_flow (annual, 2025-12-31) — Free Cash Flow: 2897071000.00
PSA cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 633500000.00
PSA cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -1113000.00
PSA cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -403000.00
PSA income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -210611000.00
PSA income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -1815000.00
PSA balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -47799000.00
PSA balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -47799000.00
PSA income_statement (annual, 2025-12-31) — General And Administrative Expense: 101807000.00
PSA income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 25291000.00
PSA balance_sheet (annual, 2025-12-31) — Goodwill: 165843000.00
PSA balance_sheet (quarterly, 2025-12-31) — Goodwill: 165843000.00
PSA balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 251613000.00
PSA balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 251613000.00
PSA balance_sheet (annual, 2025-12-31) — Gross PPE: 194355000.00
PSA balance_sheet (quarterly, 2025-12-31) — Gross PPE: 194355000.00
PSA income_statement (annual, 2025-12-31) — Gross Profit: 3514138000.00
PSA income_statement (quarterly, 2025-12-31) — Gross Profit: 886519000.00
PSA cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 6350000.00
PSA cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 492000.00
PSA income_statement (annual, 2025-12-31) — Interest Expense: 304495000.00
PSA income_statement (quarterly, 2025-12-31) — Interest Expense: 81185000.00
PSA income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 304495000.00
PSA income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 81185000.00
PSA income_statement (annual, 2025-12-31) — Interest Income: 36617000.00
PSA income_statement (quarterly, 2025-12-31) — Interest Income: 9973000.00
PSA income_statement (annual, 2025-12-31) — Interest Income Non Operating: 36617000.00
PSA income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 9973000.00
PSA cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 273007000.00
PSA cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 52488000.00
PSA balance_sheet (annual, 2025-12-31) — Invested Capital: 15152009000.00
PSA balance_sheet (quarterly, 2025-12-31) — Invested Capital: 15152009000.00
PSA cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1685089000.00